These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2157983)

  • 1. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
    N Engl J Med; 1990 Apr; 322(17):1189-94. PubMed ID: 2157983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pilot study of amiloride inhalation in children with cystic fibrosis].
    Riedler J; Huttegger I
    Klin Padiatr; 1992; 204(3):158-62. PubMed ID: 1614182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
    App EM; King M; Helfesrieder R; Köhler D; Matthys H
    Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No added benefit from nebulized amiloride in patients with cystic fibrosis.
    Graham A; Hasani A; Alton EW; Martin GP; Marriott C; Hodson ME; Clarke SW; Geddes DM
    Eur Respir J; 1993 Oct; 6(9):1243-8. PubMed ID: 8287938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.
    Hirsh AJ; Sabater JR; Zamurs A; Smith RT; Paradiso AM; Hopkins S; Abraham WM; Boucher RC
    J Pharmacol Exp Ther; 2004 Dec; 311(3):929-38. PubMed ID: 15273255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis.
    Bennett WD; Olivier KN; Zeman KL; Hohneker KW; Boucher RC; Knowles MR
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1796-801. PubMed ID: 8665037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis.
    Knowles MR; Olivier K; Noone P; Boucher RC
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S65-9. PubMed ID: 7533608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults.
    Olivier KN; Bennett WD; Hohneker KW; Zeman KL; Edwards LJ; Boucher RC; Knowles MR
    Am J Respir Crit Care Med; 1996 Jul; 154(1):217-23. PubMed ID: 8680683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    N Engl J Med; 1990 Oct; 323(14):996-8. PubMed ID: 2402269
    [No Abstract]   [Full Text] [Related]  

  • 10. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
    Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC
    N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis.
    Hofmann T; Senier I; Bittner P; Hüls G; Schwandt HJ; Lindemann H
    J Aerosol Med; 1997; 10(2):147-58. PubMed ID: 10168532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
    Mall MA
    Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME
    N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease.
    Hirsh AJ; Zhang J; Zamurs A; Fleegle J; Thelin WR; Caldwell RA; Sabater JR; Abraham WM; Donowitz M; Cha B; Johnson KB; St George JA; Johnson MR; Boucher RC
    J Pharmacol Exp Ther; 2008 Apr; 325(1):77-88. PubMed ID: 18218832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects.
    Sood N; Bennett WD; Zeman K; Brown J; Foy C; Boucher RC; Knowles MR
    Am J Respir Crit Care Med; 2003 Jan; 167(2):158-63. PubMed ID: 12411282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum.
    Tomkiewicz RP; App EM; Zayas JG; Ramirez O; Church N; Boucher RC; Knowles MR; King M
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1002-7. PubMed ID: 8214916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of amiloride and saline on nasal mucociliary clearance and potential difference in cystic fibrosis and normal subjects.
    Middleton PG; Geddes DM; Alton EW
    Thorax; 1993 Aug; 48(8):812-6. PubMed ID: 8211871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amiloride inhalation therapy in mucoviscidosis].
    Lindemann H
    Monatsschr Kinderheilkd; 1993 May; 141(5):392-4. PubMed ID: 8326957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT
    Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolized amiloride as treatment of cystic fibrosis lung disease: a pilot study.
    Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
    Adv Exp Med Biol; 1991; 290():119-28; discussion 129-32. PubMed ID: 1950741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.